Ginkgo Bioworks Holdings Inc (NYSE:DNA)
$ 0.881801 -0.052199 (-5.59%) Market Cap: 1.94 Bil Enterprise Value: 1.36 Bil PE Ratio: 0 PB Ratio: 1.60 GF Score: 19/100

Q1 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript

May 16, 2022 / 08:30PM GMT
Release Date Price: $2.43 (-8.65%)
Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

Good afternoon. This is Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. As usual, I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. Thanks again for joining us, and we look forward to providing you with an update on our last quarter.

As a reminder, during the presentation today, we'll be making some forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the Securities and Exchange Commission to learn more about these risks and uncertainties.

We'll follow our standard agenda for these calls. We'll provide an update on our financial progress while also taking an opportunity to dive deeper into an area of strategic importance as folks continue to develop a deeper understanding of what we're building. As I said before, if there are topics you'd like to see in a future deep dive, just let us know. We'd love to include those in the future. As usual, we'll end with a Q&A session, and I'll take questions from analysts,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot